Both in Pharmaceuticals
Foghorn Therapeutics vs Nkarta
Over the past year FHTX returned −52.1% and NKTX returned −25.5%; their daily moves had a correlation of 0.34.
FHTX −52.1% NKTX −25.5%Growth of $1, one year, split-adjusted
| Metric | FHTX | NKTX |
|---|---|---|
| Price | $2.13 | $1.72 |
| Market cap | $126.5M | $123.2M |
| Today | +3.90% | +1.18% |
| 1 month | −39.5% | −34.4% |
| 6 months | −55.3% | −36.1% |
| Year to date | −60.6% | −7.0% |
| 1 year | −48.3% | −26.8% |
| Revenue growth (YoY) | +112.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −44.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | — |
| Net cash | $167.6M | $182.8M |
| Dividend yield | — | — |
| Volatility (60d) | 105.8% | 61.8% |
| Short % of float | 7.3% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).